Crystal deposition measured with dual-energy computed tomography: association with mortality and cardiovascular risks in gout
Authors:
- 7 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 60 (10) , 4855-4860
Abstract
To determine whether the volume of monosodium urate (MSU) crystal deposition measured with dual-energy computed tomography (DECT) is predictive of short-term mortality and development of cardiovascular comorbidities and diabetes mellitus. Patients with a diagnosis of gout having had baseline DECT scans of their knees and feet to measure the volume of MSU crystals deposition were included to undergo a follow-up visit. Risk factors for mortality and a composite variable (onset of any cardio-metabolic event) were examined using multivariable Cox models. A total of 128 patients aged 66.1 (±14.0) years with gout durations of 11.4 (±10.4) years were included, most were naïve of urate lowering therapy (ULT) (61.7%), with a follow-up visit at 24 [12; 36] months. Baseline serum urate (SU) levels were 7.44 (±2.29) mg/dl and DECT volumes of MSU crystals were 0.2 [0; 0.9] cm3. A total of 14 patients died during follow-up and for 6/14 from a cardiovascular cause, and 17 patients presented a new cardio-metabolic comorbidity. Factors associated with mortality risk were baseline DECT volume of MSU crystals (HR 1.02, 95% CI 1.002–1.03) and baseline SU level (HR 1.04, 95% CI 1.003–1.06). DECT volume of MSU crystals was the only factor associated with the onset of cardio-metabolic comorbidities with an HR of 1.014 (95% CI 1.001–1.03). Volume of MSU crystal measured with DECT is a biomarker for the risk of developing new cardio-metabolic diseases and for all-cause mortality.Keywords
This publication has 26 references indexed in Scilit:
- 2016 updated EULAR evidence-based recommendations for the management of goutAnnals of the Rheumatic Diseases, 2017
- Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational StudyThe Journal of Rheumatology, 2016
- 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2015
- Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular diseaseCurrent Medical Research and Opinion, 2015
- Mechanisms of crystal formation in gout—a structural approachNature Reviews Rheumatology, 2015
- Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT studyAnnals of the Rheumatic Diseases, 2015
- The Gouty Tophus: a ReviewCurrent Rheumatology Reports, 2015
- Improving cardiovascular and renal outcomes in gout: what should we target?Nature Reviews Rheumatology, 2014
- Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with goutAnnals of the Rheumatic Diseases, 2014
- GOSPEL: Prospective survey of gout in France. Part I: Design and patient characteristics (n=1003)Joint Bone Spine, 2012